2017 International Congress

Thursday, June 8, 2017

1:15pm-2:45pm

A long-term study on effectiveness of levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease patients

K.R. Chaudhuri, A. Antonini, W. Poewe, D. Standaert, P. Odin, J. Zamudio, L. Bergmann (London, United Kingdom)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

A neuroimaging-based model for disease progression in Parkinson’s disease

N. Shenkov, I. Klyuzhin, A. Rahmim, V. Sossi (Vancouver, BC, Canada)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C

1:15pm-2:45pm

A novel paradigm of variable frequency deep brain stimulation to improve freezing of gait in Parkinson’s disease

F. Jia, A. Wagle Shukla, w. Hu, L. Almeida, M. Okun, L. Li (Beijing, China)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations

S. Ramaswamy, W. Wen, G. Ramaswamy, L. Friedhoff (New York, NY, USA)

Clinical Trials and Therapy in Movement Disorders  ·  Exhibit Hall C

1:15pm-2:45pm

A Phase 2, Open-Label, Dose-Escalating Study to Evaluate the Safety and Preliminary Efficacy of Daxibotulinumtoxina for Injection (RT002) in Isolated Cervical Dystonia

C. Comella, J. Jankovic, D. Truong, A. Brashear, A. Patel, M. Evatt, C. Chung, R. Rubio (Chicago, IL, USA)

Clinical Trials and Therapy in Movement Disorders  ·  Exhibit Hall C

1:15pm-2:45pm

A Phase 3 Study of isradipine as a disease modifying agent in patients with early Parkinson’s disease (STEADY-PD III): Baseline characteristics and study update

K. Biglan, J. Lowell, D. Oakes, K. Hodgeman, R. Rockhill, B. Greco, R. Holloway, T. Simuni (Rochester, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

A Pilot Multiparametric MEG Study of coherence in generalized and cervical dystonia

A. Mahajan, S. Bowyer, A. Zillgitt, P. LeWitt, P. Kaminski, C. Sidiropoulos (Detroit, MI, USA)

Dystonia  ·  Exhibit Hall C

1:15pm-2:45pm

A Preliminary Study: Validity and Reliability of Parkinson Fatigue Scale (PFS) in Turkish Patients with Parkinson’s Disease (PD)

E. Ozturk, E. Ozturk, B. Gonenli Kocer, I. Gundogdu, A. Cakci, E. Umay (Ankara, Turkey)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

A Preliminary Study: Validity and Reliability of Turkish Version of Fatigue Severity Scale (FSS) in Patients with Parkinson’s Disease (PD)

E. Ozturk, B. Gonenli Kocer, I. Gundogdu, A. Cakci, E. Umay (Ankara, Turkey)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C

1:15pm-2:45pm

A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD

H.-L. Chiang, F. Chang, D. Tsui, Y. Tai, A. Ha, N. Mahant, J. Griffith, D. Galea, S. Kim, B. Cruse, H. Morales-Briceño (New Taipei City, Taiwan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C